Bioadhesive drug formulations for oral transmucosal delivery
First Claim
Patent Images
1. A method of treating pain in a subject, comprising administering a bioadhesive tablet to the oral mucosa of a subject,wherein said tablet comprises:
- (a) from about 2.5 to about 100 micrograms of sufentanil, expressed as the base; and
(b) a bioadhesive material, wherein said bioadhesive material provides for adherence to the oral mucosa of said subject, and(c) said tablet has a volume of from about 0.1 microliters to about 50 microliters,wherein after administration of said tablet to said subject, said tablet provides a minimal saliva response and minimal swallowing of sufentanil; and
more than 50% of drug delivery of sufentanil occurs via the oral transmucosal route.
3 Assignments
0 Petitions
Accused Products
Abstract
Bioadhesive drug formulations that adhere to an oral mucosal membrane of a subject are provided together with single dose applicators and devices for delivering the drug formulations to the oral mucosa, and methods for using the same.
-
Citations
26 Claims
-
1. A method of treating pain in a subject, comprising administering a bioadhesive tablet to the oral mucosa of a subject,
wherein said tablet comprises: -
(a) from about 2.5 to about 100 micrograms of sufentanil, expressed as the base; and (b) a bioadhesive material, wherein said bioadhesive material provides for adherence to the oral mucosa of said subject, and (c) said tablet has a volume of from about 0.1 microliters to about 50 microliters, wherein after administration of said tablet to said subject, said tablet provides a minimal saliva response and minimal swallowing of sufentanil; and
more than 50% of drug delivery of sufentanil occurs via the oral transmucosal route. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)
-
Specification